Autologous bone marrow transplantation (ABMT) versus sequential chemotherapy for aggressive non Hodgkin's lymphoma (NHL) in first complete remission (CR): A study of 542 patients (LNH87-2 protocol).

被引：0
|
作者：
Haioun, C [1 ]
Lepage, E [1 ]
Gisselbrecht, C [1 ]
Coiffier, B [1 ]
Bosly, A [1 ]
Dupriez, B [1 ]
Nouvel, C [1 ]
Tilly, H [1 ]
Lederlin, P [1 ]
Biron, P [1 ]
Briere, J [1 ]
Gaulard, P [1 ]
Reves, F [1 ]
机构：
[1] HOP HENRI MONDOR,F-94010 CRETEIL,FRANCE
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1816 / 1816
页数：1
相关论文
共 50 条
  • [31] Autologous stem cell transplantation as consolidation treatment in 71 cases of aggressive non Hodgkin's lymphoma in complete or partial remission after first line therapy.
    Fanin, R
    BLOOD, 1999, 94 (10) : 400B - 400B
  • [32] Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation
    deKreuk, AM
    Ossenkoppele, GJ
    Meijer, CJLM
    Huijgens, PC
    BONE MARROW TRANSPLANTATION, 1996, 17 (06) : 963 - 971
  • [33] CONVENTIONAL CHEMOTHERAPY FOLLOWED BY CONSOLIDATION WITH AUTOLOGOUS HEMATOPOIETIC TRANSPLANTATION VS CHEMOTHERAPY ALONE IN HIV plus PATIENTS WITH LARGE B CELL LYMPHOMA (LBCL) IN FIRST COMPLETE REMISSION (CR). A RETROSPECTIVE ANALYSIS ON BEHALF OF THE EBMT LYMPHOMA WORKING PARTY AND THE GESIDA/PETHEMA REGISTRY OF HIV plus PATIENTS WITH NON-HODGKIN'S LYMPHOMA (NHL)
    Balsalobre, P.
    Berenguer, J.
    Miralles, P.
    Serrano, D.
    Ribera, J. M.
    Canals, C.
    Montes, M.
    Michieli, M.
    Valencia, E.
    Rosselet, A.
    Rodriguez-Arrondo, F.
    Genet, P.
    Galindo, M. J.
    Ferrant, A.
    Pintado, V
    Sureda, A.
    Diez-Martin, J. L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S165 - S165
  • [34] Aggressive chemotherapy followed by autologous bone marrow transplantation in newly diagnosed and relapsed low-grade non-Hodgkin's lymphoma: Preliminary results.
    Venugopal, P
    Gregory, SA
    Kaizer, H
    Showel, JL
    Riley, MB
    Jajeh, A
    Rifkin, S
    Robin, E
    Raza, A
    Preisler, HD
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (07) : A395 - A395
  • [35] High-Dose sequential (HDS) chemotherapy supplemented with rituximab: a feasible and effective first line approach for patients with aggressive and indolent Non-Hodgkin's Lymphoma (NHL)
    Ladetto, M
    Zallio, F
    Vallet, S
    Ricca, I
    Cuttica, A
    Caracciolo, D
    Corradini, P
    Astolfi, M
    Sametti, S
    Volpato, F
    Vitolo, U
    Gianni, AM
    Pileri, A
    Tarella, C
    BONE MARROW TRANSPLANTATION, 2001, 27 : S262 - S262
  • [36] Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma:: Final analysis of the prospective LNH87-2 protocol -: A Groupe d'Etude des Lymphomes de l'Adulte Study
    Haioun, C
    Lepage, E
    Gisselbrecht, C
    Salles, G
    Coiffier, B
    Brice, P
    Bosly, A
    Morel, P
    Nouvel, C
    Tilly, H
    Lederlin, P
    Sebban, C
    Brière, J
    Gaulard, P
    Reyes, F
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) : 3025 - 3030
  • [37] High-dose therapy with autologous hematopoietic stem cell transplantation for patients (pts) with low-grade follicular non-Hodgkin's lymphoma in first complete remission (CR) or partial remission (PR).
    Bociek, GR
    Bierman, PJ
    Vose, JM
    Lynch, JC
    Morris, ME
    Armitage, JO
    BLOOD, 1999, 94 (10) : 171A - 171A
  • [38] High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: A prospective randomized Italian multicenter study
    Martelli, M
    Vignetti, M
    Zinzani, PL
    Gherlinzoni, F
    Meloni, G
    Fiacchini, M
    DeSanctis, V
    Papa, G
    Martelli, MF
    Calabresi, F
    Tura, S
    Mandelli, F
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) : 534 - 542
  • [39] Ten-year results of high-dose chemotherapy (HDCT) with autologous bone marrow (ABMT) or peripheral stem cells transplantation (ASCT) as first salvage treatment for relapsed or refractory Hodgkin's lymphoma
    Viviani, S.
    Di Nicola, M.
    Bonfante, V.
    Carlostella, C.
    Valagussa, P.
    Bonadonna, G.
    Gianni, A. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 80 - 80
  • [40] Radiotherapy after high-dose chemotherapy followed by autologous bone marrow transplantation in patients with intermediate or high-grade non-Hodgkin's lymphoma
    Barra, S
    Bacigalupo, A
    Corvo, R
    Guenzi, M
    Scolaro, T
    Vitale, V
    TUMORI, 1996, 82 (04) : 335 - 338
12345